Compare TAOP & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAOP | IRIX |
|---|---|---|
| Founded | 1993 | 1989 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3M | 18.2M |
| IPO Year | 2012 | 1996 |
| Metric | TAOP | IRIX |
|---|---|---|
| Price | $1.30 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.1K | ★ 38.2K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,593,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $6.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.18 | $0.87 |
| 52 Week High | $4.69 | $1.65 |
| Indicator | TAOP | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 22.34 |
| Support Level | $1.21 | $0.87 |
| Resistance Level | $1.54 | $1.14 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 20.55 | 9.07 |
Taoping Inc is a provider of cloud-based technology solutions, smart city IoT platforms, digital advertising delivery systems, and internet-based information distribution systems in China. The company has three reportable segments. The Cloud-based Technology segment includes cloud-based products, high-end data storage servers, advertising services, and customized software solutions for private sector customers. The Traditional Information Technology segment includes project-based technology products and services sold to the public sector, including Geographic Information Systems, Digital Public Security Technology, and Digital Hospital Information Systems. The Smart Elevator segment provides elevator sales, installation, maintenance, renovation, and cloud-based maintenance services.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.